[EOLIA trial : Does ECMO confer a survival advantage in ARDS?]
- PMID: 30421139
- DOI: 10.1007/s00063-018-0511-1
[EOLIA trial : Does ECMO confer a survival advantage in ARDS?]
Comment on
-
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.N Engl J Med. 2018 May 24;378(21):1965-1975. doi: 10.1056/NEJMoa1800385. N Engl J Med. 2018. PMID: 29791822 Clinical Trial.
References
Literatur
-
- Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308 - DOI
-
- Karagiannidis C, Brodie D, Strassmann S et al (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 42:889–896 - DOI
-
- Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
